The global digital breast tomosynthesis market size is expected to reach USD 6.42 billion by 2030 registering a CAGR of 13.6%, according to a new report by Grand View Research, Inc. Rising awareness about the use of DBT, increasing prevalence of breast cancer, and introduction of technologically advanced products are the key driving factors for the market.
As per the Susan G Komen Breast Cancer Foundation Inc., in 2019, around 41,760 new cases of breast cancer will be reported. In addition, as per the data published in South African Journal of Radiology in 2018, breast cancer is one of the most common cancer type and is one of the leading causes of death in South Africa. Such factors are anticipated to drive the market over the forecast period.
Favorable reimbursement policies are also anticipated to boost the market growth. For instance, Brazilian Ministry of Health has given recommendations for tomosynthesis for the screening of breast cancer. Furthermore, several advantages of DBT are also expected to increase the product demand. For instance, as per the Breast Cancer Organization, after getting the U.S. Food and Drug Administration (FDA) approval, 3D breast tomosynthesis systems are witnessing higher demand than 2D systems.
Request a free sample copy or view report summary: Digital Breast Tomosynthesis Market Report
In terms of revenue, standalone 3D systems segment held the largest share in 2023 owing to high prevalence of breast cancer across the globe
Diagnostics centers segment is expected to witness the fastest CAGR over the forecast period owing to increasing awareness about DBT in both developed and developing countries
Asia Pacific digital breast tomosynthesis market is anticipated to witness significant growth in the global market. The rising burden of breast cancer leading to increased demand for innovative and technologically advanced cancer-detecting medical devices is the major contributing factor to the market growth in this region.
Grand View Research has segmented the global digital breast tomosynthesis market report based on product, end use, and region:
Digital Breast Tomosynthesis Product Outlook (Revenue, USD Million, 2018 - 2030)
2D/3D Combination Systems
Standalone 3D Systems
Digital Breast Tomosynthesis End Use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Diagnostics Centers
Others
Digital Breast Tomosynthesis Regional Outlook (Revenue, USD Million; 2018-2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Mexico
MEA
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in Digital Breast Tomosynthesis Market
Hologic, Inc.
GE Healthcare
Siemens Healthineers
FUJIFILM Corporation
PerkinElmer
CANON MEDICAL SYSTEMS CORPORATION
Internazionale Medico Scientifica
Analogic Corporation
Trivitron Healthcare
"The quality of research they have done for us has been excellent..."